Cargando…

Integrated Network Pharmacology Analysis and Serum Metabolomics to Reveal the Anti-malaria Mechanism of Artesunate

[Image: see text] Artesunate is a widely used drug in clinical treatment of malaria. The aim of this study was to investigate the therapeutic mechanism of artesunate on malaria using an integrated strategy of network pharmacology and serum metabolomics. The mice models of malaria were established us...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Feiran, Song, Jian, Yan, Yingying, Zhou, Qian, Li, Xiaojing, Wang, Ping, Yang, Zongtong, Zhang, Qiuhong, Zhang, Huimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453802/
https://www.ncbi.nlm.nih.gov/pubmed/36092633
http://dx.doi.org/10.1021/acsomega.2c04157
_version_ 1784785219979575296
author Wang, Feiran
Song, Jian
Yan, Yingying
Zhou, Qian
Li, Xiaojing
Wang, Ping
Yang, Zongtong
Zhang, Qiuhong
Zhang, Huimin
author_facet Wang, Feiran
Song, Jian
Yan, Yingying
Zhou, Qian
Li, Xiaojing
Wang, Ping
Yang, Zongtong
Zhang, Qiuhong
Zhang, Huimin
author_sort Wang, Feiran
collection PubMed
description [Image: see text] Artesunate is a widely used drug in clinical treatment of malaria. The aim of this study was to investigate the therapeutic mechanism of artesunate on malaria using an integrated strategy of network pharmacology and serum metabolomics. The mice models of malaria were established using 2 × 10(7) red blood cells infected with Plasmodium berghei ANKA injection. Giemsa and hematoxylin-eosin (HE) staining were used to evaluate the efficacy of artesunate on malaria. Next, network pharmacology analysis was applied to identify target genes. Then, a metabolomics strategy has been developed to find the possible significant serum metabolites and metabolic pathways induced by artesunate. Additionally, two parts of the results were integrated to confirm each other. Giemsa and HE staining results showed that artesunate significantly inhibited the proliferation of Plasmodium and reduced liver and spleen inflammation. Based on metabolomics, 18 differential endogenous metabolites were identified as potential biomarkers related to the artesunate for treating malaria. These metabolites were mainly involved in the relevant pathways of biosynthesis of unsaturated fatty acids; aminoacyl-tRNA biosynthesis; valine, leucine, and isoleucine biosynthesis; and phenylalanine, tyrosine, and tryptophan biosynthesis. The results of the network pharmacology analysis showed 125 potential target genes related to the treatment of malaria with artesunate. The functional enrichment was mainly associated with lipid and atherosclerosis; pathways of prostate cancer and proteoglycans in cancer; and PI3K-Akt, apoptosis, NF-κB, Th17 cell, and AGE-RAGE signaling pathways. These findings were partly consistent with the findings of the metabolism. Our results further suggested that artesunate could correct the inflammatory response caused by malaria through Th17 cell and NF-κB pathways. Meanwhile, our work revealed that cholesterol needed by Plasmodium berghei came directly from serum. Cholesterol and palmitic acid may be essential in the growth and reproduction of Plasmodium berghei. In summary, artesunate may have an effect on anti-malarial properties through multiple targets.
format Online
Article
Text
id pubmed-9453802
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-94538022022-09-09 Integrated Network Pharmacology Analysis and Serum Metabolomics to Reveal the Anti-malaria Mechanism of Artesunate Wang, Feiran Song, Jian Yan, Yingying Zhou, Qian Li, Xiaojing Wang, Ping Yang, Zongtong Zhang, Qiuhong Zhang, Huimin ACS Omega [Image: see text] Artesunate is a widely used drug in clinical treatment of malaria. The aim of this study was to investigate the therapeutic mechanism of artesunate on malaria using an integrated strategy of network pharmacology and serum metabolomics. The mice models of malaria were established using 2 × 10(7) red blood cells infected with Plasmodium berghei ANKA injection. Giemsa and hematoxylin-eosin (HE) staining were used to evaluate the efficacy of artesunate on malaria. Next, network pharmacology analysis was applied to identify target genes. Then, a metabolomics strategy has been developed to find the possible significant serum metabolites and metabolic pathways induced by artesunate. Additionally, two parts of the results were integrated to confirm each other. Giemsa and HE staining results showed that artesunate significantly inhibited the proliferation of Plasmodium and reduced liver and spleen inflammation. Based on metabolomics, 18 differential endogenous metabolites were identified as potential biomarkers related to the artesunate for treating malaria. These metabolites were mainly involved in the relevant pathways of biosynthesis of unsaturated fatty acids; aminoacyl-tRNA biosynthesis; valine, leucine, and isoleucine biosynthesis; and phenylalanine, tyrosine, and tryptophan biosynthesis. The results of the network pharmacology analysis showed 125 potential target genes related to the treatment of malaria with artesunate. The functional enrichment was mainly associated with lipid and atherosclerosis; pathways of prostate cancer and proteoglycans in cancer; and PI3K-Akt, apoptosis, NF-κB, Th17 cell, and AGE-RAGE signaling pathways. These findings were partly consistent with the findings of the metabolism. Our results further suggested that artesunate could correct the inflammatory response caused by malaria through Th17 cell and NF-κB pathways. Meanwhile, our work revealed that cholesterol needed by Plasmodium berghei came directly from serum. Cholesterol and palmitic acid may be essential in the growth and reproduction of Plasmodium berghei. In summary, artesunate may have an effect on anti-malarial properties through multiple targets. American Chemical Society 2022-08-24 /pmc/articles/PMC9453802/ /pubmed/36092633 http://dx.doi.org/10.1021/acsomega.2c04157 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Wang, Feiran
Song, Jian
Yan, Yingying
Zhou, Qian
Li, Xiaojing
Wang, Ping
Yang, Zongtong
Zhang, Qiuhong
Zhang, Huimin
Integrated Network Pharmacology Analysis and Serum Metabolomics to Reveal the Anti-malaria Mechanism of Artesunate
title Integrated Network Pharmacology Analysis and Serum Metabolomics to Reveal the Anti-malaria Mechanism of Artesunate
title_full Integrated Network Pharmacology Analysis and Serum Metabolomics to Reveal the Anti-malaria Mechanism of Artesunate
title_fullStr Integrated Network Pharmacology Analysis and Serum Metabolomics to Reveal the Anti-malaria Mechanism of Artesunate
title_full_unstemmed Integrated Network Pharmacology Analysis and Serum Metabolomics to Reveal the Anti-malaria Mechanism of Artesunate
title_short Integrated Network Pharmacology Analysis and Serum Metabolomics to Reveal the Anti-malaria Mechanism of Artesunate
title_sort integrated network pharmacology analysis and serum metabolomics to reveal the anti-malaria mechanism of artesunate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453802/
https://www.ncbi.nlm.nih.gov/pubmed/36092633
http://dx.doi.org/10.1021/acsomega.2c04157
work_keys_str_mv AT wangfeiran integratednetworkpharmacologyanalysisandserummetabolomicstorevealtheantimalariamechanismofartesunate
AT songjian integratednetworkpharmacologyanalysisandserummetabolomicstorevealtheantimalariamechanismofartesunate
AT yanyingying integratednetworkpharmacologyanalysisandserummetabolomicstorevealtheantimalariamechanismofartesunate
AT zhouqian integratednetworkpharmacologyanalysisandserummetabolomicstorevealtheantimalariamechanismofartesunate
AT lixiaojing integratednetworkpharmacologyanalysisandserummetabolomicstorevealtheantimalariamechanismofartesunate
AT wangping integratednetworkpharmacologyanalysisandserummetabolomicstorevealtheantimalariamechanismofartesunate
AT yangzongtong integratednetworkpharmacologyanalysisandserummetabolomicstorevealtheantimalariamechanismofartesunate
AT zhangqiuhong integratednetworkpharmacologyanalysisandserummetabolomicstorevealtheantimalariamechanismofartesunate
AT zhanghuimin integratednetworkpharmacologyanalysisandserummetabolomicstorevealtheantimalariamechanismofartesunate